Autologous Fat Grafting in Cosmetic Breast Augmentation: A Systematic Review on Radiological Safety, Complications, Volume Retention, and Patient/Surgeon Satisfaction.

Aesthetic surgery journal 2016 Vol.36(9) p. 993-1007

Groen JW, Negenborn VL, Twisk JW, Ket JC, Mullender MG, Smit JM

관련 도메인

Abstract

[BACKGROUND] Autologous fat grafting (AFG) is increasingly used in cosmetic surgery. However, its efficacy and safety are still ambiguous. Both a comprehensive overview and recapitulation of the relevant literature provide current evidence on the efficacy and outcomes of AFG in cosmetic breast surgery.

[OBJECTIVES] This review provides an up-to-date overview of the literature on AFG in cosmetic breast augmentation.

[METHODS] A systematic review of the literature on AFG used for cosmetic breast augmentation was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. This study included selected studies that were published between January 1996 and February 2016 and reported on 10 patients or more who had a minimal mean follow-up period of 1 year.

[RESULTS] In this study, 22 articles that reported on 3565 patients with follow-up periods ranging from 12 to 136 months were included. A complication rate of 17.2% (95% CI 15.9-18.5) was seen. Indurations were the most frequent complication (33.3%, 95% CI 20.4-46.3), followed by persistent pain (25%, 95% CI 0.5-49.5), and hematoma (16.4%, 95% CI 14.5-18.4). Mammograms revealed micro-calcifications (9.0%, 95% CI 6.4-11.5) and macro-calcifications (7.0%, 95% CI 3.8-10.2). The mean volume retention was 62.4% (range, 44.7-82.6%), with a satisfaction rate of 92% in patients and 89% in surgeons.

[CONCLUSIONS] AFG is a promising method in achieving autologous cosmetic breast augmentation with satisfactory volume retention and satisfaction rates in eight and six studies, respectively. Complications and radiological findings are comparable to those after implant augmentation. Future studies should focus on cancer occurrence and detection to further substantiate AFG safety. In addition, grafting methods and the use of auxiliary procedures to identify factors leading to better outcomes in terms of volume retention should be investigated. Finally, objective questionnaires are needed to represent patient satisfaction.

[LEVEL OF EVIDENCE] 3 Therapeutic.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 5
시술 breast augmentation 유방성형술 dict 4
해부 Fat scispacy 1
합병증 hematoma 혈종 dict 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 CI 6.4 scispacy 1
약물 [CONCLUSIONS] AFG scispacy 1
질환 Volume Retention scispacy 1
질환 cosmetic breast augmentation scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 micro-calcifications scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 Patient/Surgeon scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1

MeSH Terms

Adipose Tissue; Calcinosis; Female; Humans; Mammaplasty; Mammography; Patient Satisfaction; Personal Satisfaction; Postoperative Care; Postoperative Complications; Transplantation, Autologous

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문